The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A study of pembrolizumab (pembro) in combination with Y90 radioembolization in patients (pts) with poor prognosis hepatocellular carcinoma (HCC).
 
Ashwin Somasundaram
No Relationships to Disclose
 
Paul R. Helft
No Relationships to Disclose
 
William Proctor Harris
Consulting or Advisory Role - BD Medical; Bristol-Myers Squibb; Eisai; Exelixis; Merck; Merck; Neo Therma; QED therapeutics; Zymeworks
Research Funding - Agios (Inst); ArQule (Inst); Bayer (Inst); Boston Scientific (Inst); Bristol-Myers Squibb (Inst); BTG (Inst); Exelixis (Inst); Halozyme (Inst); Koo Foundation (Inst); MedImmune (Inst); Merck (Inst); zymeworks (Inst)
Travel, Accommodations, Expenses - Eisai
 
Hanna Kelly Sanoff
Research Funding - Amgen (Inst); AstraZeneca (Inst); BioMed Valley Discoveries (Inst); Bristol-Myers Squibb (Inst); Exelixis (Inst); Pfizer (Inst); Rgenix (Inst); Roche (Inst)
 
Guy E. Johnson
No Relationships to Disclose
 
Menggang Yu
Consulting or Advisory Role - Merck
 
Matthew Johnson
No Relationships to Disclose
 
Bert O'Neil
Employment - Lilly
Honoraria - AstraZeneca
 
Autumn Jackson McRee
Employment - Janssen Research & Development
Stock and Other Ownership Interests - Johnson and Johnson
Research Funding - AstraZeneca (Inst); BioMed Valley Discoveries (Inst); Boston Biomedical (Inst); Inovio Pharmaceuticals (Inst); Merck (Inst); Novartis (Inst); Rgenix (Inst); Takeda (Inst)